BusinessGalectin Therapeutics to Webcast Corporate Presentation at the MicroCap Conference on October 25 in PhiladelphiaBy Nasdaq OMXOct 17, 2016, 12:30 PM UTC
BusinessGalectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot Trial (NASH-FX) with GR-MD-02 in NASH Patients with Advanced FibrosisBy Nasdaq OMXSep 27, 2016, 8:15 PM UTC
BusinessGalectin Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment ConferenceBy Nasdaq OMXAug 31, 2016, 12:00 PM UTC
